本文/YA9255C
|
|
- ありみち なつ
- 5 years ago
- Views:
Transcription
1 pp. E- -SH X in vitro in vivo -SH Structure-based drug development and medical biological application of cathepsin specific inhibitors Nobuhiko Katunuma Institute for Health Sciences, Tokushima Bunri University,Nishihamabouji, Yamashirocho, Tokushima City, Tokushima, Japan -SH
2 -SH E- V. Turk Huber CA- CA- B Ki M L CLIK- CLIK- S CLIK- K CLIK- CLIK- X M B L S K CA- CA- CLICK- CLIK- CLIK- CLIK- CLIK- CA- CA- B R. Huber D. Turk B X B occluding loop His His C C CA- B CA- CA- B Ki M in vitro in vivo L CLIK- X S CLIK- S S K B K CLIK- CLIK- CLIK- S K E- CA- Sigma CLIK limited proteolysis
3 9 5 4 生化学 第8 1巻 第1 1号 図1 個々のカテプシン群に対する特異 的阻害剤4 7 図2 CA-0 3 0のカテプシン B 群に対する特異 的結合 X 線共結晶解析による9
4 2 0 0 9年 1 1月 9 5 5 図3 CLIK-1 4 8のカテプシン L に対する特異的結合 X 線共結晶解析による19 図4 抗原提示 T リンパ球のクラススイッチに対 するカテプシン類の関与
5 L T Th IgG a IFNγ CLIK- B T Th IgE IgG L- CA- CA- T Th CA- Th Th CLIK- L IgE IgG IL-IgG a IFNγ Th CA- B CA- B Th Th PCA
6 b C T H B a B Z-RR-MCA B MCA -Methyl-Coumaryl- -Amide a - E- µg ml E- µg ml E-µg ml E- µg ml b - CA- µg ml CA- µg ml CA- µg ml CA- µg ml a T C B H B ER B C CA- E-R a B S Sjögren α- α-fodrin CLIK- S α- S CLIK- b
7 a α- T B CLIK- T α- H CLIK- TxNFS non-txnfs NFS b CLIK- S CLIK- CLIK- α- S CLIK- S I L K L K RANCL a
8 a L b CLIK- A CLIK- L TNFα E- CLIK- L TNFα A CLIK-b bioactive receptor S MHC II MHC II B L H
9 L CLIK L Ii L Km Ki M H L B A L CLIK- G.P. Shi L CLIK- - MHC II S IL- -STAT S CLIK- MHC IIα-β Ii L CLIK- - K CLIK- - IgE B CA- CA- CLIK- CLIK- - S CLIK- Turk, V., Turk, B., & Turk, D.EMBO J.,,. Umezawa, H., Morishita, T., Kunimoto, S., & Takeuchi, T. J. Antibiot.,,. Hanada, K., Tamai, M., Yamagishi, M., Ohmura, S., Sawada, J., & Tanaka, I.Agric. Biol. Chem.,,. Murata, M., Miyashita, S., Yokoo, C., Tamai, M., Hanada, K., Hatayama, K., Towatari, T., Nikawa, T., & Katunuma, N. FEBS Lett.,,. Katunuma, N., Murata, E., Kakegawa, H., Matsui, A., Tsuzuki, H., Tsuge, H., Turk, D., Turk, V., Fukushima, M., Tada, Y., & Asao, T.FEBS Lett.,,. Katunuma, N. & Kominami, E.Methods Enzymo.,,. Katunuma, N., Matsui, A., Inubushi, T., Murata, E., Kakegawa, H.,Ohba,Y.,Turk,D.,Turk,V.,Tada,Y.,&Asao,T. Biochem. Biophys. Res. Commun.,,. Musil, D., Zucic, D., Turk, D., Engh, R.A., Mayr, I., Huber,
10 R., Popovic, T., Turk, V., Towatari, T., Katunuma, N., et al. EMBO J.,,. Turk, D., Podobnik, M., Popovic, T., Katunuma, N., Bode, W., Huber, R., & Turk, V.Biochemistry,,. Katunuma, N., Tsuge, H., Nukatsuka, M., Asao, T., & Fukushima, M.Arc. Biochem. Biophys.,,. Matsunaga, Y., Saibara, T., Kido, H., & Katunuma, N. FEBS Lett.,,. Maekawa, Y., Himeno, K., Ishikawa, H., Hisaeda, H., Sakai, T., Dainichi, T., Asao, T., Good, R.A., & Katunuma, N. J. Immunol.,,. Katunuma, N., Kakegawa, H., Matsunaga, Y., & Saibara, T. FEBS Lett.,,. Kamon, H., Sawa, S., Park, S.J., Katunuma, N., Ishihara, K., Murakami, M., & Hirano, T.Immunity,,. Saegusa, K., Ishimaru, N., Yanagi, K., Arakaki, R., Ogawa, K., Saito, I., Katunuma, N., & Hayashi, Y.J. Clin. Invest.,,. Kitamura, H., Kamon, H., Sawa, S., Park, S.J., Katunuma, N., Ishihara, K., Murakami, M., & Hirano, T.Immunity,,. Nagaya, T., Murata, Y., Yamaguchi, S., Nomura, Y., Ohmori, S., Fujieda, M. & Katunuma, N., Yen, P.M., Chin, W.W., & Seo, H.J. Biol. Chem.,,. Yang, M., Zhang, Y., Pan, J., Sun, J., Liu, J., Libby, P., Sukhova, G.K., Doria, A., Katunuma, N., Peroni, O.D., Guerre- Millo, M., Kahn, B.B., Clement, K., & Shi, G-P.Nat. Cell Biol.,,. Tsuge, H., Nishimura, T., Tada, Y., Asao, T., Turk, D., Turk, V., & Katunuma, N.Biochem. Biophys. Res. Commun.,,.
nsg02-13/ky045059301600033210
φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W
More information研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
More information1) van Meer, G., Op den Kamp, J. A.: J. Cell. Biochem., 19, 193-2040982) 2) Gaffet, P., Bettache, N., Bienvenue, A.: Biochemistry, 34, 6762-6769(1995) 3) Sims, P. J., Wiedmer, T.: Thromb. Haemost., 86,
More information第14〜15回 T細胞を介する免疫系.pptx
MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α
More informationNovel chemical mediators in the resolution of inflammation Charles N. Serhan Key words E-mail : marita@nih.go.jp Charles N. Serhan Brigham & Women's Hospital/Harvard Medical School 1) Serhan, C. N.,
More informationdrug development Toshimi Michigami, E-mail : michigami@mch.pref.osaka.jp Keiichi Ozono, E-mail : keioz@ped.med.osaka-u.ac.jp The progress in the research on vitamin D 1) McCollum, E. V. et al.:
More information2007050781......_.L.O...z.W
a s d f g a s d f g h j k l 0 in vitro in vivo in vitro in vivo in vivo in vivo in vitro Metabolism Metabolism Endocr Endocr Endocrinol Ann NYA cad Sci J clin Endocr Metab
More informationCorrelation between molecular evolution of P450s and evolution of plant secondary metabolism Masaharu Mizutani E-mail : mizutani@scl.kyoto-u.ac.jp URL : http://biofun.kuicr.kyoto-u.ac.jp/index-j.html 13)
More information第86回日本感染症学会総会学術集会後抄録(I)
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
More information表1.eps
Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol
More information本文/YA4278I
pp. D- D-DAO DAO D- D- D- D- o- DAO-D- D-DAO DAO Hans Krebs FAD X DAO DAO DAO D- Structure and reaction mechanism of D-amino acid oxidase Yasuzo Nishina School of Health Sciences, Kumamoto University,
More informationThe function and structure of NAD kinase: the key enzyme for biosynthesis of NADP (H) Database Center for Life Science Online Service Key words Shigey
The function and structure of NAD kinase: the key enzyme for biosynthesis of NADP (H) Key words Shigeyuki Kawai, Chikako Fukuda, Kousaku Murata E-mail : kawais@kais.kyoto-u.ac.jp, chikakko@kais.kyotou.ac.jp,
More informationO1-1 O1-2 O1-3 O1-4 O1-5 O1-6
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35
More information1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
More information19 8 1970 20 10 4 1
19 8 1970 20 10 4 1 IgE 1960 % 1970 20%, 1990 40% 1998 70% 20 IgE 21 90% IgE IgE (%) 70 60 50 40 30 20 10 0 1970 1975 1980 1985 1990 1995 2000 2005 1. 2005 10 2 30 IgE 2. 3 1. B IgE T IgE IgE IgE 2 T IgE
More informationuntitled
RYZA IL & FAT CHEMICAL C., LTD. SAKURA EXTRACT Ver.1.4MK Ver. 1.4MK 1) 1300 1929 1 Ver. 1.4MK Sakura 1-caffeoyl---D-glucopyranoside quercetin 3---D-glucopyranoside 1) :, 4, 11-22 (1995). 2 Ver. 1.4MK 3
More informationDatabase Center for Life Science Online Service (http : // taxonomy.zoology.gla.ac.uk/rod/treeview.html) Takaaki Abe, Michiaki Unno*, Tohru Onogawa*,
(http : // taxonomy.zoology.gla.ac.uk/rod/treeview.html) Takaaki Abe, Michiaki Unno*, Tohru Onogawa*, E mail : takaabe@mail.cc.tohoku.ac.jp Taro Tokui, Molecular identification of organic anion transporter
More informationBio-No.57/3....
2004. MAR. 3No.57 http://www.wako-chem.co.jp C O N T E N T S 2 Wako Bio Window No.57 MAR.2004 l l l l wako wako l l mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm Wako Bio Window No.57 MAR.2004 3 4 Wako Bio Window
More informationÿþ
インターロイキン インターロイキンは リンパ球や単球 マクロファージなどの免疫反応への寄与が知られる白血球から産生されることから 細胞間 ( inter-) 白血球 ( leukocyte -leukin) より Interleukin と名づけられました 現在までに 30 種類以上のインターロイキンが同定され 発見された順番に番号が付与されており 中にはケモカイン ( IL-8) やインターフェロン
More informationVarious function and toxicity of iron Key words 1) Hentze, M. W. et al: Cell, 117, 285-297 (2004) 2) Ganz, T.: Blood, 102, 783-788 (2003) 3) Nemeth, E. et al.: Science, 306, 2090-2093 (2004) 4) Hentze,
More informationKazumitsu Ueda, [Department of Applied Life Science, Kyoto University Graduate School of Agriculture, Kitashirakawa, Sakyo-ku, Kyoto 606-01, Japan] Molecular Mechanisms for Drug Transport by MDR1/P-glycoprotein
More informationCAR-T実施
Building a Clinical CAR-T Program - Jichi Medical University Experience l l l Anti-CD3/28 mabs & IL-2: 29% Anti-CD3/28 beads: 66% Retroviral: 41% Lentiviral: 54% T-Flasks: 22% Static Culture Bags: 35%
More information本文/AY380L
RNA- RNA RNA Nanotechnology & Therapeutics Lexington RNA Salt Lake City FNANO FNANO RNA RNA RNA- RNP RNA DNA DNA DNA RNA RNA ips CiRA RNA-Protein nanotechnology & synthetic biology Hirohide Saito The Hakubi
More information研究成果報告書
X-SCID T NK Omenn T T 2007 2008 0menn T 1. 研究開始当初の背景 T T T T reversion T T 2. 研究の目的 RAG1/RAG2 Artemis T TCR T TCR 3. 研究の方法 RAG1/RAG2 μ μ μ μ μ μμ μμ μ 解析ダイアグラム 3-D display による TCR 多様性の評価 4. 研究成果 TCR T
More informationReview Fumio Imamoto1, Takefumi Sone1, Kazuhide Yahata1, Yukari Sasaki1, Masatoshi Takagi2, Kazuhiro Maeshima2, Naoko 25) Dong, W. K. et al.: Gene, 91, 217-223 (1990) 26) Masatsugu, T. et al.:
More informationzsj2017 (Toyama) program.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
More information88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
More information_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
More information2 3 5 5 5 5 6 6 7 7 8 10 10 10 10 11 11 12 12 13 16 16 16 16 17 19 21 21 22 5
1D000425-2 1 2 3 5 5 5 5 6 6 7 7 8 10 10 10 10 11 11 12 12 13 16 16 16 16 17 19 21 21 22 5 3 29 29 29 30 31 31 32 35 35 35 36 41 41 41 46 48 48 48 52 57 4 700 13 1988 4 5 4 5 21 1 1 3 4 5 6 21 10 1888
More information経済論集 46‐2(よこ)(P)☆/2.三崎
1 2 1869 11 17 5 10 1 3 1914 5 15 5 1872 9 12 3 1870 1 26 14 1881 11 11 12 6 11 1878 5 9 13 1880 6 17 1 15 1882 1 2 3 11 1828 2 26 24 1891 4 22 2 1849 12 1 3 1856 pp 20 21. 1971 p.429. 1973 1, pp.440 444.
More informationnsg04-28/ky208684356100043077
δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!
More information[Nippon Nogeikagaku Kaishi
[ Nippon Nageikagaku Kaishi Vol. 72, No. 11, pp. 1333 `1344, 1998 l Key words: methylotrophic yeast; gene expres sion; C1-metabolism; peroxisome Cellular Functions of the Methylotrophic Yeast: Their Molecular
More informationMATSUNAGA
MATSUNAGA MATSUNAGA 1 a a a a 2 3 a 4 5 a a a a a 6 a a 7 a a a a 8 9 a a a a a a 10 a a a a 11 a a a 12 a a a a 13 a a a 14 a a a 15 a a a 16 a a a a 17 a a 18 19 a a 20 21 a a 22 a 23 24 25 26 27 28
More informationi ii ( ) ( ) ( ) 462,891 525,032 502,164 230,636 CD CD 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 10 10 11 10 12 11 13 11 14 12 15 12 16 13 16 14 17 15 18 15 18 16 19 17 20 17 18 19
More informationTomohiro Terada, Ken-ichi Inui, Peptide transporter family situ 1) Matthews, D.M. : Physiol. Rev., 55, 537-608(1975) 2) Ganapathy, V.. Leibach, F.H.: Am. J. Physiol. Gastro intest. Liver Physiol.,
More information日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら
α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α
More information2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1
More information第6号-2/8)最前線(大矢)
最前線 免疫疾患における創薬標的としてのカリウムチャネル 大矢 進 Susumu OHYA 京都薬科大学薬理学分野教授 異なる経路を辿る 1つは マイトジェンシグナル 1 はじめに を活性化し 細胞増殖が促進されるシグナル伝達経 路 図1A 右 であり もう1つはカスパーゼやエ 神 経 筋 の よ う な 興 奮 性 細 胞 で は カ リ ウ ム ンドヌクレアーゼ活性を上昇させ アポトーシスが K
More information秋田応用微生物研究会
13:00-13:10 13:10-13:30 13:30-13:50 (Tricholoma auratum) 13:50-14:10 14:10-14:30 14:30-14:50 14:50-15:10 α-msh 15:10-15:30 Lewis 15:30-15:50 15:50-16:10 16:10-16:30 (1) (2) ( ) (2) (1) (2) (3) (1) (2)
More informationSpecial IssueManagement principles in the critically ill - Review Case reports et al et al et al et al Nutritional management in critically ill patients Akiko Mano, Emiko Nakataki, Harutaka Yamaguchi,
More information本文/YA7261E
J. Cell Biol.,,. Segev, N.Curr. Opin. Cell Biol.,,. Lafont, F., Lecat, S., Verkade, P., & Simons, K.J. Cell Biol.,,. Mostov, K.E., Verges, M., & Altschuler, Y.Curr. Opin. Cell Biol.,,. Sato, T., Mushiake,
More information(a) (b) (c) (d) 1: (a) (b) (c) (d) (a) (b) (c) 2: (a) (b) (c) 1(b) [1 10] 1 degree k n(k) walk path 4
1 vertex edge 1(a) 1(b) 1(c) 1(d) 2 (a) (b) (c) (d) 1: (a) (b) (c) (d) 1 2 6 1 2 6 1 2 6 3 5 3 5 3 5 4 4 (a) (b) (c) 2: (a) (b) (c) 1(b) [1 10] 1 degree k n(k) walk path 4 1: Zachary [11] [12] [13] World-Wide
More information15K00827 研究成果報告書
(TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem
More information第62巻5・6号(12月号)/特集1・巻頭言
Special Issue 1Recent advances in radiation diagnosis and radiation therapy Special Issue 2The way and the power for overcoming diabetes mellitus Review Originals Current topics on radiation exposure
More informationVOL33NO.3/2010 A B A B p-erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 Erk1/2 Time (min) 0 1 2 5 10 15 30 60 90 120 p-vasp VASP C D enos/gapdh x-fold vs sham 2.0 1.5 1.0 0.5 * 0 ANP (-) (+) (-)
More information_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
More information
本文/YA9255F
pp. ATP ε ATP ATP ATP ε Bacillus PS ATP ATP H H µ H ATP ATP ADP µ H ATP FoF -ATP FoF -ATP µ H H ADP ATP H Na On the regulatory role of the epsilon subunit in ATP synthase Yasuyuki Kato-Yamada Department
More information第59巻4,5号(10月号)/投稿規定・目次・表2・奥付・背
Special IssuePhysiology, psychology and treatment of eating disorders Reviews Originals Proceeding Case Report ob α α et al. et al et al Control of food intake Kyoichi Kishi, Kazuhito Rokutan, Takeshi
More information第58巻6号/投稿規定・目次・表2・奥付・背
Feature articles 1Why is it that allergic diseases have been increasing? Feature articles 2Space medicine and medicine for the future Review γ ε γ γ γγ α αβ et al et al et al et al et al et al Is nutritional
More informationDatabase Center for Life Science Online Service Discovery, analysis and chemical mechanism of protein splicing
Discovery, analysis and chemical mechanism of protein splicing VMA1 VMA1 2) Anraku, Y.: Genes to Cells, 2, 359-367 (1997) 3) Perler, F. B.: Cell, 92,1-4 (1998) 4) Perler, F. B.: Trends Biochem.
More informationEstablishment and progress of Sendai virus engineering 2) Schnell, M. J., Mebatsion, T., Conzelmann, K.-K.: EMBO J., 13,4195-4203(1994) 3) Kato, A. et al.: Genes Cells, 1, 569-579 (1996) 4) Nagai,
More informationLactobacillus brevis γ
Lactobacillus brevis γ γ Lactobacillus brevis Pentaphylloides fruticosa National Institute of Fruit Tree Science, NARO, 2 1 Fujimoto, Tsukuba Ibaraki 305 8605 Key wordsethylene, fruit quality, shelf life,
More informationNL10
Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
More informationβ β β β β β
β β β β β β β β β β β β β β β β β θ β α γ et al et al et al β β et al β et al in vivo et al γ et al et al et al et al et al et al Ectopic fat deposition, type 2 diabetes mellitus and cardiovascular diseases
More informationVol.53 No. 11 (2008) 1327
Molecules that regulate morphology of the plasma membrane Shiro Suetsugu, Kazunori Takano E-mail : suetsugu@iam.u-tokyo.ac.jp 1326 Vol.53 No. 11 (2008) Vol.53 No. 11 (2008) 1327 1328 Vol.53 No. 11 (2008)
More informationaisatu.pdf
1 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71
More informationDatabase Center for Life Science Online Service Natronobacterium pharaonis Crystal structure of phoborhodopsin : Mechanisms of color tuning and signal
Natronobacterium pharaonis Crystal structure of phoborhodopsin : Mechanisms of color tuning and signal transduction Needleman, R., Lanyi, J. K. : Science, 269,73-75 (1995) 3) Bogomolni, R. A., Stoeckenius,
More information(Quality of Life; QL) QL (Nerve Growth Factor; NGF) NGF PC12 6- (6-HITC) NGF NGF NGF PTP1B 6-HITC PTP1B NGF PTP1B 6-HITC PTP1B 6-HITC NGF 6-HITC 6-HITC in vivo 464-8601 Tel: 052-789-4126 20-Hydroxyecdysone
More informationtary adenylate cyclase activating polypeptide ; PA-
Conformation of a peptide ligand bound to its G-protein coupled receptor and its implication for ligand transportation tary adenylate cyclase activating polypeptide ; PA- molecular biology (ed. Rich,
More information一休デイサービスセンター
2770105472 2770105472 2776300135 2776300135 - - 072-274-7219 072-204-7319 http://www.19day.jp/ 072-274-7219 072-204-7319 http://www.19day.jp/ 2007 11 1 45 2007 11 1 45 11 12 4km 10 11 -2- 3-3 - 4 - 5 11
More informationCandida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents
D 012 Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents DATA : 1 DATA : 2 3 DATA : UNGITEC 1 1 DATA : 20pg/mL 1020pg/mL 10pg/mL (cut off 20pg/mL) 90.2%(37/41) 100%(85/85) 96.8%(122/126)
More informationMicrosoft Word _前立腺がん統計解析資料.docx
治療症例数第 6 位 : (2015/1-2017/9) 統計解析資料 A) はじめに免疫治療効果の成否に大きく関与するT 細胞を中心とした免疫機構は 細胞内に進入した外来生物の排除ならびに対移植片拒絶や自己免疫疾患 悪性腫瘍の発生進展に深く関与している これら細胞性免疫機構は担癌者においてその機能の低下が明らかとなり 近年では腫瘍免疫基礎研究において各種免疫学的パラメータ解析によるエビデンスに基づいた治療手法が大きく注目されるようになった
More information